Global Artificial Tears Market Size by Growth Rate, Business Challenges, Competitors, and Forecast 2035

Dry Eye Disease Prevalence and Aging Populations Increase Demand for Artificial Tears Across Global Healthcare Markets

The global Artificial Tears market was valued at USD 4.83 Billion in 2025 and is projected to reach USD 8.91 Billion by 2035, registering a revenue CAGR of 6.3% during the forecast period, according to the latest analysis by Reports and Data.

NEW YORK, June 11, 2026 - The global Artificial Tears market was valued at USD 4.83 Billion in 2025 and is expected to reach USD 8.91 Billion by 2035, registering a revenue CAGR of 6.3% during the forecast period.

Demand for artificial tears continues to increase as the prevalence of dry eye disease rises worldwide. Growing screen exposure, aging populations, and increased diagnosis rates are contributing to higher product adoption across both prescription and over-the-counter channels. According to the World Health Organization (WHO), the global population aged 60 years and older is expected to nearly double between 2020 and 2050, increasing the number of individuals susceptible to age-related ocular conditions. In addition, ophthalmology associations including the American Academy of Ophthalmology have reported increasing clinical attention toward dry eye management due to changing lifestyle and environmental factors.

Key Growth Drivers
The market is benefiting from rising awareness of ocular health, expanding access to eye care services, and continued product innovation in preservative-free formulations. Healthcare providers are increasingly recommending artificial tears as a first-line treatment option for mild to moderate dry eye symptoms. The growing use of digital devices across workplaces, educational institutions, and households is also contributing to higher incidence of eye strain and tear film instability. Manufacturers are investing in advanced formulations designed to improve moisture retention and patient comfort. For instance, in May 2023, Bausch + Lomb, United States, launched MIEBO for the treatment of dry eye disease associated with meibomian gland dysfunction following regulatory approval. These are some of the key factors driving revenue growth of the Artificial Tears market.

Get Sample Link: https://www.reportsanddata.com/request-sample/114

Market Restraints
However, product recalls, regulatory scrutiny regarding sterility standards, and intense competition among generic and private-label brands continue to create challenges for market participants. Several regulatory agencies, including the U.S. Food and Drug Administration (FDA), have increased oversight of ophthalmic products following contamination-related incidents, leading to higher compliance requirements for manufacturers. Price sensitivity in developing markets and limited reimbursement coverage for certain over-the-counter products may also affect adoption rates. These factors are expected to limit Artificial Tears market growth to some extent over the forecast period.

Segment Highlights
Based on product type, the preservative-free artificial tears segment accounted for the largest revenue share in the market. These products are widely preferred by patients requiring frequent application because they reduce the risk of ocular irritation associated with long-term preservative exposure. Increasing physician recommendations and consumer awareness continue to support demand for preservative-free formulations.

The liquid drops segment is expected to remain the fastest-growing product category during the forecast period. Liquid formulations are easy to administer, readily available through retail and online channels, and suitable for a broad range of dry eye conditions. Continued expansion of e-commerce distribution is further improving product accessibility for consumers.

Regional Outlook
North America accounted for a leading share of the global Artificial Tears market due to high diagnosis rates of dry eye disease, favorable healthcare infrastructure, and strong presence of major manufacturers. The United States remains a key contributor to regional demand. Companies such as Alcon and Bausch + Lomb continue to expand their ophthalmic product portfolios through product launches and clinical development initiatives. Increased FDA approvals for ophthalmic treatments are also supporting market growth.

Europe continues to represent a substantial share of the market, supported by aging demographics and growing awareness of eye health. Countries including Germany, France, and the United Kingdom have well-established ophthalmology care networks that support product adoption. The European Commission has also emphasized healthy aging initiatives that indirectly contribute to increased management of age-related ocular conditions. Major regional participants continue to invest in preservative-free and specialty eye care products.

Asia Pacific is expected to register the fastest growth during the forecast period. Rapid urbanization, increasing digital device usage, and expanding healthcare access are driving demand across countries such as China, Japan, South Korea, and India. According to government health statistics in several Asia Pacific countries, rising healthcare expenditure and growing access to eye care services continue to improve diagnosis and treatment rates for ocular disorders. Companies are expanding local manufacturing and distribution networks to address increasing demand from the region's large patient population.

Browse Full Report: https://www.reportsanddata.com/report-detail/artificial-tears-market

Segmentation Insights
1. End Use Outlook (Revenue, USD Billion, 2025 - 2035)
Hospitals
Ophthalmology Clinics
Homecare Settings
2. Distribution Channel Outlook (Revenue, USD Billion, 2025 - 2035)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
3. Delivery Format Outlook (Revenue, USD Billion, 2025 - 2035)
Eye Drops
Multi-Dose Bottles
Single-Use Vials
Spray Formulations
4. Product Type Outlook (Revenue, USD Billion, 2025 - 2035)
Preserved Artificial Tears
Preservative-Free Artificial Tears
Ointments
Gels
5. Regional Outlook (Revenue, USD Billion, 2025 - 2035)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Others
Latin America
Brazil
Others
Middle East and Africa (MEA)
KSA
UAE
South Africa
Request Customization: https://www.reportsanddata.com/request-customization-form/114

Media Contact
Contact: Debanjan Biswas
Company: Reports and Data
Email:sales@reportsanddata.com
Website:www.reportsanddata.com

About Reports and Data
Reports and Data is a market research and consulting firm that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics and industries to help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market.

This release was published on openPR.